Basic Fact Sheet Detailed Version Basic fact sheets are presented in plain language for individuals with general questions about sexually transmitted diseases. This is because the same behaviors and circumstances that may put you at risk for getting an STD can also put you at greater risk for getting HIV.
HIV blood tests and results Diagnosis is made through a blood test that screens specifically for the virus. If HIV has been found, the test result is "positive.
If a person has been exposed to the virus, it is crucial that they get tested as soon as possible. The earlier HIV is detected, the more likely the treatment will be successful. A home testing kit can be used as well. After infection with HIV, it can take from 3 weeks to 6 months for the virus to show up in testing.
Re-testing may be necessary.
If the moment an individual was most at risk of infection was within the last 6 months, they can have the test immediately. However, the provider will urge that another test is carried out within a few weeks. Treatment Treatment The red ribbon is the worldwide symbol of support and awareness for people living with HIV.
Treatments can stop the progression of the condition and allow most people living with HIV the opportunity to live a long and relatively healthy life. It is now established that, given the right treatment, someone living with HIV can reduce his or her viral load to such a degree that it is no longer detectable.
After assessing a number of large studies, the CDC concluded that individuals who have no detectable viral load "have effectively no risk of sexually transmitting the virus to an HIV-negative partner. Emergency HIV pills post-exposure prophylaxis If an individual believes they have been exposed to the virus within the last 72 hours 3 daysanti-HIV medications, called PEP post-exposure prophylaxis may stop infection.
The treatment should be taken as soon as possible after contact with the virus. PEP is a treatment lasting 4 weeks, a total of 28 days. Monitoring for HIV will be continued after completion of the treatment.
The treatment fights the HIV infection and slows down the spread of the virus in the body. There are a number of subgroups of antiretrovirals; these include: Protease inhibitors Protease is an enzyme that HIV needs to replicate.
As the name suggests, protease inhibitors bind to the enzyme and inhibit its action, preventing HIV from making copies of itself. Integrase inhibitors HIV needs the integrase enzyme to infect T cells. This drug prevents that step. Integrase inhibitors are often used in the first line of treatment because they are effective for many people, and cause minimal side effects.
They are rarely used in America because other drugs are more effective. Without access to these cells, HIV cannot replicate. As with chemokine co-receptor antagonists, they are rarely used in the United States. A combination of these drugs will be used; the exact mix of drugs is adapted to each individual.
HIV treatment is usually permanent and lifelong. HIV treatment is based on routine dosage. Pills must be taken on a regular schedule, every time.
Each class of ARVs has different side effects, but some possible common side effects include:EDITOR’S NOTE: Although the underlying ideas and messages in this article remain relevant, much HIV prevention research has been published since , notably about there being effectively no risk of transmitting the virus if you are HIV positive and undetectable (a.k.a.
treatment as prevention, or TasP), as well as the effectiveness of pre-exposure prophylaxis (PrEP). The following table was published in Sept/Oct by the now-defunct Continuum magazine (and I expect elsewhere).
It was part of an article by Christine Johnson, of HEAL Los Angeles. The introduction and list of 64 references from 'HIV' literature are not reproduced here.
Roxanne Dryden-Edwards, MD. Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Journal articles on HIV Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.
Selected Journal Articles on HIV/AIDS To search this page, type "Ctrl+F" on a PC or "Command+F" on a Mac and enter a keyword or phrase Starred items indicate research conducted by VA scientists, funded by the VA, or involving VA patients.
Symptoms of HIV in men depend upon the stages of this fatal disease. If detected at an early stage, can be treated well and easily.